11 – 20 of 84
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Tasquinimod Modulates Suppressive Myeloid Cells and Enhances Cancer Immunotherapies in Murine Models
- Contribution to journal › Article
-
Mark
Extracellular MRP8/14 is a regulator of β2 integrin-dependent neutrophil slow rolling and adhesion.
- Contribution to journal › Article
-
Mark
S100A9 as a pharmacological target molecule in inflammation and cancer.
- Contribution to journal › Article
-
Mark
Prophylactic treatment with S100A9 inhibitor paquinimod reduces pathology in experimental collagenase-induced osteoarthritis.
- Contribution to journal › Article
-
Mark
Myeloid-related protein 14 promote inflammation and injury in meningitis.
- Contribution to journal › Article
-
Mark
S100A9 expressed in ER(-)PgR(-) breast cancers induces inflammatory cytokines and is associated with an impaired overall survival.
- Contribution to journal › Article
-
Mark
Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment.
- Contribution to journal › Article
-
Mark
Vesicular Location and Transport of S100A8 and S100A9 Proteins in Monocytoid Cells.
- Contribution to journal › Article
- 2014
-
Mark
The quinoline-3-carboxamide paquinimod (ABR-215757) reduces leukocyte recruitment during sterile inflammation: Leukocyte- and context-specific effects.
- Contribution to journal › Article
-
Mark
High density of S100A9 positive inflammatory cells in prostate cancer stroma is associated with poor outcome.
- Contribution to journal › Article
